Bhatnagar Anish insider trades

Open-market stock purchases and sales by Bhatnagar Anish, CHIEF EXECUTIVE OFFICER at Soleno Therapeutics Inc, from SEC Form 4 filings since Nov 12, 2014.

Recent trades

DateStockTradeValue
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)—
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$994K
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$1.2M
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$1.2M
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$43.2K
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$190K
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$1.1M
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$3.7M
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$5.7M
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$5.7M
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$1.4K
May 18, 2026SLNO Soleno Therapeutics IncSold (not open market)$127K
Jan 21, 2026SLNO Soleno Therapeutics IncBought (not open market)—
Jan 21, 2026SLNO Soleno Therapeutics IncBought (not open market)—
Dec 15, 2025SLNO Soleno Therapeutics IncSold (not open market)$381K
Dec 15, 2025SLNO Soleno Therapeutics IncSold (not open market)—

Companies traded

  • SLNO Soleno Therapeutics Inc: 1 buy, 40 sales, last May 18, 2026
  • CAPN Capnia, Inc: 3 buys, last Apr 19, 2017

Get free alerts when Bhatnagar Anish files a new trade →